HalioDx is Now Part of Veracyte! Learn About HalioDx Read the Press Release
HalioDx is Now Part of Veracyte! Learn About HalioDx Read the Press Release
Skip to content
Veracyte is a leading genomic diagnostics company that is fundamentally improving patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable. The company’s products uniquely combine genomic technology, clinical science and machine learning to provide answers that give physicians and patients a clear path forward without risky, costly surgery that is often unnecessary.
Since its founding in 2008, Veracyte has commercialized three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis and collectively target a $2 billion market opportunity. Veracyte is based in South San Francisco, California. Veracyte’s common stock is listed on The NASDAQ Global Market under the symbol VCYT.


Press Releases

Date Title and Summary Additional Formats
Toggle Summary New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
- Findings from Analysis Evaluating Test In Newly Diagnosed, Clinically High-Risk Disease to be Highlighted in ASTRO Press Program - SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 14, 2021-- Veracyte, Inc. (Nasdaq: VCYT) announced that new data further validating the clinical utility of the
Toggle Summary New Publication Demonstrates Ability of Veracyte’s Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 13, 2021-- Veracyte, Inc ., (Nasdaq: VCYT) announced today the publication of new data demonstrating that the company’s Decipher Bladder genomic classifier accurately identifies bladder tumors that are most likely to respond to chemotherapy prior


Date Event Details
Summary Toggle Nov 9, 2021 1:30 PM PST
Veracyte Third Quarter 2021 Financial Results Webcast


Title Documents

Corporate Presentation August 2021